You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors

Citation Tools

Article menu
Oncolytic and local immunotherapy
Original research
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Zhu Y, Elsheikha HM, Wang J, et al
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors
Journal for ImmunoTherapy of Cancer 2021;9:e002970. doi: 10.1136/jitc-2021-002970